主页
市场
图表与思路
Algo
新闻
商店
经纪商
下载
经济日历
交易信号
网页端
热图
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ALXO
#3604
ALX Oncology Holdings Inc. Common Stock
1.6
8
USD
+3.70%
版块:
医疗保健
基础:
USD
利润货币:
USD
日范围
年范围
日变化
+3.70%
每月变动
-18.05%
6个月变化
+3.07%
年变化
+205.45%
前一天收盘价
1.6
2
开盘价
1.6
8
买价
卖价
最低价
1.6
8
High
1.6
8
交易量
27
市场
股票
医疗保健
ALXO
展开完整图表
Financials
概览
声明
统计
每季度
年度
Market Capitalization
221.1 M
Employee
43
Founded
2015
CEO
N/A
Website
www.alxoncology.com
Headquarter
Delaware, United States
FIGI
BBG00VR8SDG8
Industry
生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
总收入
0
221.1 M
市值
净利润
-22.85 M
新闻
ALDX Crashes 71% as FDA Issues Third CRL for Dry Eye Disease Drug NDA
CTMX Stock Rallies on Strong Phase I Colorectal Cancer Study Data
IBRX Stock Jumps on Progress in NK Cell Therapy Production
JNJ's Bladder Cancer Therapy Meets Key Goal in Early-Stage Study
RARE's DTX301 Meets First Key Goal in Phase III OTC Deficiency Study
RLMD Stock Surges 42% in a Week: Here's What You Should Know
GSK Out-Licenses Rights for Rare Liver Disease Drug to Alfasigma
EDIT Stock Up on Narrower-Than-Expected Q4 Loss, Revenues Rise Y/Y
Roche's Giredestrant Misses Key Goal in First-Line Breast Cancer Study
LRMR Stock on the Move: What Sparked the 55% Jump in the Past Month?
QURE Stock Crashes 32% in a Week: Here's What You Should Know
Mirum Completes Enrollment & Screening in Liver Disease Studies